Fibroblast growth factors (FGFs) deliver extracellular signals that govern many developmental and regenerative processes, but the mechanisms regulating FGF signaling remain incompletely understood. Here, we explored the relationship between intrinsic stability of FGF proteins and their biological activity for all 18 members of the FGF family. We report that FGF1, FGF3, FGF4, FGF6, FGF8, FGF9, FGF10, FGF16, FGF17, FGF18, FGF20, and FGF22 exist as unstable proteins, which are rapidly degraded in cell cultivation media. Biological activity of FGF1, FGF3, FGF4, FGF6, FGF8, FGF10, FGF16, FGF17, and FGF20 is limited by their instability, manifesting as failure to activate FGF receptor signal transduction over long periods of time, and influence specific cell behavior in vitro and in vivo. Stabilization via exogenous heparin binding, introduction of stabilizing mutations or lowering the cell cultivation temperature rescues signaling of unstable FGFs. Thus, the intrinsic ligand instability is an important elementary level of regulation in the FGF signaling system.

Department of Anatomy Histology and Embryology University of Veterinary and Pharmaceutical Sciences Brno Czech Republic

Zobrazit více v PubMed

Itoh N, Ornitz DM. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn. 2008;237:18–27. doi: 10.1002/dvdy.21388. PubMed DOI

Itoh N. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res. 2010;342:1–11. doi: 10.1007/s00441-010-1024-2. PubMed DOI PMC

Copeland RA, Ji H, Halfpenny AJ, Williams RW, Thompson KC, Herber WK, Thomas KA, Bruner MW, Ryan JA, Marquis-Omer D. The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch Biochem Biophys. 1991;289(1):53–61. doi: 10.1016/0003-9861(91)90441-K. PubMed DOI

Culajay JF, Blaber SI, Khurana A, Blaber M. Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life. Biochemistry. 2000;39:7153–7158. doi: 10.1021/bi9927742. PubMed DOI

Zakrzewska M, Krowarsch D, Wiedlocha A, Otlewski J. Design of fully active FGF-1 variants with increased stability. Protein Eng Des Sel. 2004;17:603–611. doi: 10.1093/protein/gzh076. PubMed DOI

Buczek O, Krowarsch D, Otlewski J. Thermodynamics of single peptide bond cleavage in bovine pancreatic trypsin inhibitor (BPTI) Protein Sci. 2002;11:924–932. doi: 10.1110/ps.4460102. PubMed DOI PMC

Zakrzewska M, Krowarsch D, Wiedlocha A, Olsnes S, Otlewski J. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action. J Mol Biol. 2005;352:860–875. doi: 10.1016/j.jmb.2005.07.066. PubMed DOI

Damon DH, Lobb RR, D’Amore PA, Wagner JA. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J Cell Physiol. 1989;138:221–226. doi: 10.1002/jcp.1041380202. PubMed DOI

Derrick T, Grillo AO, Vitharana SN, Jones L, Rexroad J, Shah A, Perkins, Spitznagel TM, Middaugh CR. Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2) J Pharm Sci. 2007;96:761–776. doi: 10.1002/jps.20797. PubMed DOI

Chen G, Gulbranson DR, Yu P, Hou Z, Thomson JA. Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells. 2012;30:623–630. doi: 10.1002/stem.1021. PubMed DOI PMC

Econs MJ, McEnery PT. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab. 1997;82(2):674–681. doi: 10.1210/jcem.82.2.3765. PubMed DOI

White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 2001;60(6):2079–2086. doi: 10.1046/j.1523-1755.2001.00064.x. PubMed DOI

Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM, Clausen H. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem. 2006;281(27):18370–18377. doi: 10.1074/jbc.M602469200. PubMed DOI

Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23. Bone. 2007;40(5):1190–1195. doi: 10.1016/j.bone.2006.12.062. PubMed DOI

Colvin JS, White AC, Pratt SJ, Ornitz DM. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development. 2001;128(11):2095–2106. PubMed

Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002;16(7):870–879. doi: 10.1101/gad.965702. PubMed DOI PMC

Usui H, Shibayama M, Ohbayashi N, Konishi M, Takada S, Itoh N. Fgf18 is required for embryonic lung alveolar development. Biochem Biophys Res Commun. 2004;322(3):887–892. doi: 10.1016/j.bbrc.2004.07.198. PubMed DOI

Vincentz JW, McWhirter JR, Murre C, Baldini A, Furuta Y. Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis. 2005;41(4):192–201. doi: 10.1002/gene.20114. PubMed DOI

Lu SY, Sheikh F, Sheppard PC, Fresnoza A, Duckworth ML, Detillieux KA, Cattini PA. FGF-16 is required for embryonic heart development. Biochem Biophys Res Commun. 2008;373(2):270–274. doi: 10.1016/j.bbrc.2008.06.029. PubMed DOI PMC

Cholfin JA, Rubenstein JL. Patterning of frontal cortex subdivisions by Fgf17. Proc Natl Acad Sci USA. 2007;104(18):7652–7657. doi: 10.1073/pnas.0702225104. PubMed DOI PMC

Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S. Fgf10 is essential for limb and lung formation. Nat Genet. 1999;21(1):138–141. doi: 10.1038/5096. PubMed DOI

Zakrzewska M, Wiedlocha A, Szlachcic A, Krowarsch D, Otlewski J, Olsnes S. Increased protein stability of FGF1 can compensate for its reduced affinity for heparin. J Biol Chem. 2009;284:25388–25403. doi: 10.1074/jbc.M109.001289. PubMed DOI PMC

Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J Morphol. 1951;88:49–92. doi: 10.1002/jmor.1050880104. PubMed DOI

Plant MR, MacDonald ME, Grad LI, Ritchie SJ, Richman JM. Locally released retinoic acid repatterns the first branchial arch cartilages in vivo. Dev Biol. 2000;222:12–26. doi: 10.1006/dbio.2000.9706. PubMed DOI

Krejci P, Prochazkova J, Smutny J, Chlebova K, Lin P, Aklian A, Bryja V, Kozubik A, Wilcox WR. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone. 2010;47:102–110. doi: 10.1016/j.bone.2010.03.021. PubMed DOI PMC

Krejci P, Salazar L, Goodridge HS, Kashiwada TA, Schibler MJ, Jelinkova P, Thompson LM, Wilcox WR. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. J Cell Sci. 2008;121:272–281. doi: 10.1242/jcs.017160. PubMed DOI

Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res. 2004;297:152–164. doi: 10.1016/j.yexcr.2004.03.011. PubMed DOI

Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;27:15292–15297. PubMed

Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 2006;281:15694–15700. doi: 10.1074/jbc.M601252200. PubMed DOI PMC

Wu X, Ge H, Gupte J, Weiszmann J, Shimamoto G, Stevens J, Hawkins N, Lemon B, Shen W, Xu J, Veniant MM, Li YS, Lindberg R, Chen JL, Tian H, Li Y. Co-receptor requirements for fibroblast growth factor-19 signaling. J Biol Chem. 2007;282:29069–29072. doi: 10.1074/jbc.C700130200. PubMed DOI

Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007;27:3417–3428. doi: 10.1128/MCB.02249-06. PubMed DOI PMC

Krejci P, Krakow D, Mekikian PB, Wilcox WR. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr Res. 2007;61:267–272. doi: 10.1203/pdr.0b013e318030d157. PubMed DOI

Raucci A, Laplantine E, Mansukhani A, Basilico C. Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem. 2004;279:1747–1756. doi: 10.1074/jbc.M310384200. PubMed DOI

Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 2005;118:5089–5100. doi: 10.1242/jcs.02618. PubMed DOI

Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991;64:841–848. doi: 10.1016/0092-8674(91)90512-W. PubMed DOI

Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metab. 2012;16:693–705. doi: 10.1016/j.cmet.2012.11.001. PubMed DOI

Burke CJ, Volkin DB, Mach H, Middaugh CR. Effect of polyanions on the unfolding of acidic fibroblast growth factor. Biochemistry. 1993;32:6419–6426. doi: 10.1021/bi00076a015. PubMed DOI

Lavinder JJ, Hari SB, Sullivan BJ, Magliery TJ. High-throughput thermal scanning: a general, rapid dye-binding thermal shift screen for protein engineering. J Am Chem Soc. 2009;131:3794–3795. doi: 10.1021/ja8049063. PubMed DOI PMC

Fasman GD. Circular dichroism and conformational analysis of biomolecules. New York: Plenum Press; 1996.

Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat. 2012;33:29–41. doi: 10.1002/humu.21636. PubMed DOI PMC

Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2:REVIEWS3005. doi: 10.1186/gb-2001-2-3-reviews3005. PubMed DOI PMC

Faham S, Lindardt RJ, Rees DC. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr Opin Struct Biol. 1998;8:578–586. doi: 10.1016/S0959-440X(98)80147-4. PubMed DOI

Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R. Structural specifity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci USA. 2003;100:2357–2362. doi: 10.1073/pnas.0437842100. PubMed DOI PMC

Jayasundar R, Singh VP. In vivo temperature measurements in brain tumors using proton MR spectroscopy. Neurol India. 2002;50:436–439. PubMed

Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Maternal fever and birth outcome: a prospective study. Teratology. 1998;58:251–257. doi: 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L. PubMed DOI

Structural analysis of the stable form of fibroblast growth factor 2 - FGF2-STAB

Computer-aided engineering of stabilized fibroblast growth factor 21

Skeletal dysmorphology and mineralization defects in Fgf20 KO mice

Ligand bias underlies differential signaling of multiple FGFs via FGFR1

Liposomes Affect Protein Release and Stability of ITA-Modified PLGA-PEG-PLGA Hydrogel Carriers for Controlled Drug Delivery

Computer-assisted stabilization of fibroblast growth factor FGF-18

Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2

Healing and Angiogenic Properties of Collagen/Chitosan Scaffolds Enriched with Hyperstable FGF2-STAB® Protein: In Vitro, Ex Ovo and In Vivo Comprehensive Evaluation

Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics

Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies

Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480